ALT5 Sigma Corporation (NASDAQ:ALTS) (FRA:5AR1), a fintech firm specializing in institutional and merchant crypto solutions, today provided an update on its substantial $WLFI digital asset holdings, reporting a treasury valued at approximately $1.31 billion and highlighting the token’s active trading on established crypto exchanges.
As of its latest disclosure, ALT5 Sigma holds 7,283,585,650 $WLFI tokens. Based on a market price of $0.18 per token as of 9:30 AM ET on September 4, 2025, the company’s digital asset treasury is valued at approximately $1.31 billion.
The $WLFI token serves as the foundational digital asset for ALT5 Sigma’s treasury strategy and became available for trading on established crypto exchanges on September 1, 2025, making it accessible to public market crypto investors. Following its launch, $WLFI recorded a spot trading volume of $4.7 billion within 24 hours, positioning it among the top 10 most-traded assets by volume on its opening day.
Considering 124,946,728 shares of common stock and 99,000,000 pre-funded warrants, totaling 223,946,728 shares assuming warrant exercise, ALT5 Sigma’s treasury assets represent approximately 32.52 $WLFI tokens per share. At current prices, this implies a treasury value of $5.85 per share, also assuming the exercise of pre-funded warrants. These calculations do not account for shares underlying other warrants, convertible preferred stock, convertible debt, or outstanding restricted stock units.
Founded in 2018, ALT5 Sigma Corporation is a fintech company providing blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safekeeping of digital assets. The company has processed over $5 billion USD in cryptocurrency transactions since its inception and has been a constituent of the Russell Microcap Index since June 28, 2024.
ALT5 Sigma offers two primary platforms through its subsidiary, ALT5 Sigma, Inc.: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway enabling registered merchants globally to accept and make crypto payments, with options to convert to fiat or receive digital assets, and integrates with platforms like WooCommerce via plugins, widgets, and APIs. ALT5 Prime functions as an electronic over-the-counter (OTC) trading platform for approved customers to buy and sell digital assets using fiat currency. It is accessible via web browsers, the ‘ALT5 Pro’ mobile application, FIX API, and Broadridge Financial Solutions’ NYFIX gateway.
Separately, ALT5 Sigma is advancing the separation of its biotech business, which will operate as Alyea Therapeutics Corporation. This division is focused on developing non-addictive pain-relieving drugs, including JAN123, a novel low-dose naltrexone formulation granted Orphan Drug Designation by the FDA for treating Complex Regional Pain Syndrome (CRPS).
